OPRX
Published on 05/11/2026 at 10:06 am EDT
OptimizeRx Corporation announced the launch of a new programmatic connection point between OptimizeRx?s proprietary EHR network and DSPs, enabling media buyers to activate scalable, point of care campaigns within their existing programmatic workflows. This launch also opens up new access for OptimizeRx to the programmatic market, estimated at 90% of the total U.S. digital display ad spend across all industries. Life sciences media buyers have long faced a tradeoff: activate high-impact campaigns within the EHR through managed programs or buy programmatically with limited or unverified access to real clinical decision moments.
With this launch, media buyers can now combine the speed, control, and transparency of programmatic buying with the precision to reach HCPs directly in their clinical workflow. Media buyers will be able to activate EHR campaigns faster, directly through their DSP, self-manage the reach, frequency, and scale of EHR placements, and seamlessly incorporate EHR advertising into their omnichannel strategies. DSPs can now integrate OptimizeRx?s EHR publisher network directly into their native platform environment, giving their life sciences clients access to premium point of care inventory within existing buying workflows.
By connecting OptimizeRx?s proprietary EHR network to their programmatic platforms, DSPs can provide marketers with authenticated, bot-free EHR inventory previously unavailable at scale, differentiate their offerings with a high-value channel tailored to the needs of their life sciences clients, and capture an increased share of the $19,000 million pharma digital ad market by meeting the demand for greater point of care access.